Riskpilot← Back to searchSign inGet full accessPaxifex AB
ABActiveOrg 5592001076Samuel Bagges Väg 28 BGeneral medical practice activities · NACE 8621Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
+45% vs 2023
Equity ratio
7.1%
Financial strength
Net profit 2024
SEK -142K
-99% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -75K | +45% |
| Net profit | SEK -142K | -99% |
| Total assets | SEK 10,2M | +13% |
| Equity | SEK 726K | -16% |
| Employees | 0 | — |
Legal name
Paxifex AB
Org number
5592001076
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 mars 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet skall vara att bedriva läkarverksamhet, medicinsk konsult-, forsknings- och utbildningsverksamhet samt rådgivning inom hälso- och sjukvård, friskvård, läkemedel, restaurang, livsmedel, medicinsk teknik, IT, e-handel och kosttillskott, samt verka inom försäljning av kosttillskott, företagsledning, investeringar i fast och lös egendom, marknadsföring, tidningsutgivning och event, samt därmed förenlig verksamhet.
Address
Samuel Bagges Väg 28 B
Phone
+46730252525
Email
peter@funmed.sde
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 022 | 1 090 | 119 | 114 | 0 |
| Staff expenses | — | — | −46 | −45 | — |
| EBITDA | 529 | 286 | −165 | −137 | −75 |
| Depreciation & amort. | −18 | −18 | −18 | −18 | −18 |
| EBIT | 511 | 268 | −183 | −155 | −93 |
| Net financials | 404 | — | −86 | 84 | −49 |
| Profit before tax | 657 | 269 | −269 | −71 | −142 |
| Tax | −111 | −58 | — | — | −0 |
| Net profit | 546 | 211 | −269 | −71 | −142 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 821 | 3 448 | 3 454 | 9 012 | 10 172 |
| Equity | 998 | 1 208 | 939 | 868 | 726 |
| Long-term debt | 0 | 0 | — | 4 358 | 4 358 |
| Short-term debt | 1 823 | 2 240 | 2 514 | 3 786 | 5 087 |
| Total debt | 1 823 | 2 240 | 2 514 | 8 144 | 9 445 |
EBITDA margin
-7500000.0%
This company
15.8%
Market median
-47468454% vs market
20202024
Equity ratio
7.1%
This company
38.2%
Market median
-81% vs market
20202024
Return on equity
-19.6%
This company
18.4%
Market median
-207% vs market
20202024
Net profit margin
-14200000.0%
This company
8.1%
Market median
-175308742% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
13.01×
This company
0.62×
Market median
-1998% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Paxifex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Martin | Chief Executive Officer | 0 companies |
| Kajsa Ulrika B Snygg Martin | Deputy Board Member | 0 companies |
| Oscar Julius Martin Martin | Deputy Board Member | 0 companies |